logo-loader
viewHarvest One Cannabis Inc

Cannabis companies Harvest One and WeedMD hail successful first phase of TruTrace's pilot with Shoppers Drug Mart

Licenced producers joined the program in part to assure stakeholders that the medical cannabis industry is serious about offering a verified, standardized cannabis treatment option

Harvest One Cannabis Inc - Cannabis companies Harvest One and WeedMD hail successful first phase of TruTrace's pilot with Shoppers Drug Mart
The first phase of the program is complete and full implementation is expected in November 2019

Cannabis companies Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) and WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) have hailed the successful completion of the first phase of a pilot program to verify and track medicinal cannabis with the help of Canada’s largest pharmacy, Shoppers Drug Mart.

The program is being undertaken in conjunction with TruTrace Technologies Inc’s (CSE:TTT) (OTCMKTS:TTTSF) StrainSecure platform, a blockchain-enabled technology that is designed to increase the transparency and validation of products within the medical cannabis industry.

StrainSecure’s technology collects plant testing data and performs genomic verification on the plants to be stored and tracked in a database.

READ: TruTrace Technologies successfully completes first phase of StrainSecure pilot with Shoppers Drug Mart

Licenced producers and consumer packaged goods companies joined the program in an effort to assure stakeholders that the medical cannabis industry is serious about offering a verified, standardized cannabis treatment option to patients.

"Now that we have completed Phase 1 of the Pilot Project, medically-registered patients can have an increased level of confidence in the consumption of our Satipharm branded cannabis through Shoppers," said Grant Froese, Harvest One’s CEO.

The health and wellness company joined TruTrace’s master genome strain and clone registration program in February to verify its United Greeneries cannabis strains, one of the early adopters of StrainSecure.

Medical cannabis producer WeedMD saw 40 of its medical cannabis strains included as part of the first phase of the pilot program.

“WeedMD has long recognized the importance of strain validation,” said Keith Merker, CEO of WeedMD. “As health care practitioners look to prescribe, trust and better understand cannabis science, we’re proud to confirm that 40 WeedMD strains were used in the completion of this pilot project.”

The pilot program was first announced in June 2019 and is expected to be fully implemented by November 2019.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Harvest One Cannabis Inc

Price: 0.21 CAD

TSX-V:HVT
Market: TSX-V
Market Cap: $45.08 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Harvest One Cannabis Inc named herein, including the promotion by the Company of Harvest One Cannabis Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Harvest One Cannabis receives Health Canada cultivation...

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) Senior Vice President of Corporate & Public Affairs Will Stewart tells Proactive the cannabis company has earned a cannabis cultivation license from Health Canada for phase one of its Mission Road facility in Duncan, British...

on 15/10/19

2 min read